Jitendra Narayan
BioinformaticsOnline(BOL) admin
Tag cloud
Bioinformatics, Computational Biology, R, Genomics, Cancer, Tutorial, Education, Python, Perl, Genome Size, Virus, Genes, Biggest Virus, Ancient Root, Megavirus, Pandoraviruses, Webinar, Video, India, Genomics Research, USA, Jobs, useR! Conference, Python Classes, Python Training, Google Classes, R Tutorial, Learn R, Try R, Omics, InterpretOmics, Bangalore, Lateral gene transfer PLOS, BioPython, DNA Codes, Pharmacogenomics, UK, Cambridge, Hinxton, Wellcome Trust Genome Campus, Bioinformatics Training, California, Foodborne, Pathogen, Genome Project, Gabor, Beginners, Experts, Selective Sequencing, BAC
Our Sponsors
InterpretOmics
By Jitendra Narayan 4120 days ago Comments (6)
InterpretOmics, a big data analytics startup that focuses on life sciences, has received angel funding of around Rs 10 crore from a group of investors including Singapore's information technology and shipping company, Amarante.
Comments
http://economictimes.indiatimes.com/news/emerging-businesses/startups/biotech-data-analytics-startup-interpretomics-raises-rs-10-crore/articleshow/21719659.cms
It looks like a very good initiative in genomics sector ....
Curoverse is a new platform for the dawning era of biomedical big data
https://curoverse.com/
Jobs:
https://curoverse.com/about/jobs/
iLab Solutions is the leader in providing web-based management services to academic research institutions with customers that include leading NIH-funded universities, research hospitals, and independent institutes.
http://www.ilabsolutions.com/
Jobs:
http://www.ilabsolutions.com/ilab-careers/
Gentris
To help pharmaceutical companies and clinical research organizations effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective compounds to the market more quickly.
Jobs:
http://www.gentris.com/about/careers/
Integragen- Clinical genomics company in France
IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests for autism and oncology based on these discoveries.